Committee Connection


Clement A. Adebamowo, MD, ScD, is an Associate Professor in the Department of Epidemiology and Preventive Medicine within the School of Medicine & Institute of Human Virology at the University of Maryland, Director of the Office of Strategic Information and Research Institute of Human Virology in Nigeria, and serves on the Editorial Boards of the Journal of Clinical Oncology and the Annals of Surgical Oncology. He previously served as Chair of ASCO's International Affairs Committee. Follow Dr. Adebamowo on Twitter @adebamowo.

Edward P. Balaban, DO, FACP, FASCO, is the Medical Director for the Cancer Care Partnership with Penn State University Cancer Institute and Professor of Medicine Penn State Hershey Cancer Institute. He currently serves as a Practice Guideline Implementation Network (PGIN) representative for Weight-Based Dosing Chemotherapy for Cancer Patients and Gastrointestinal Guideline Advisory Groups. Dr. Balaban is also Past President of the Pennsylvania Society of Oncology and Hematology and the alternate delegate representing ASCO at the AMA-House of Delegates.

Jonathan S. Berek, MD, MMS, FASCO, is Editor-in-Chief of ASCO Connection. Dr. Berek is the Laurie Kraus Lacob Professor and Director of the Stanford Women's Cancer Center at the Stanford Cancer Institute, where he specializes in gynecologic oncology, and Chair of the Department of Obstetrics and Gynecology at Stanford University School of Medicine. Dr. Berek currently serves on ASCO's Scientific Program Committee and Integrated Media and Technology Committee. He has been Editor-in-Chief of ASCO Connection (previously ASCO News & Forum) since 2004.

Douglas W. Blayney, MD, FASCO, a medical oncologist, is the Ann and John Doerr Medical Director of the Stanford Cancer Institute and a Professor at Stanford University School of Medicine. He is an ASCO Past President, Chair of the QOPI Oversite Committee, and currently serves as a member of the Quality of Care, Bylaws and CancerLinQ Advisory Committees and the Cost of Cancer Task Force.
Anees B. Chagpar, MD, MSc, MA, MPH, FACS, FRCS(C), a breast surgical oncologist, is Director of the Breast Center - Smilow Cancer Hospital at Yale-New Haven; Assistant Director of the Yale Cancer Center, responsible for Diversity and Health Equity; and Associate Professor in the Department of Surgery at Yale School of Medicine. She was part of the inaugural ASCO Leadership Development Program and has served as Chair of ASCO's Innovation Grants Selection Committee and as a member of ASCO's International Affairs Committee. Follow Dr. Chagpar on Twitter @AneesChagpar
John V. Cox, DO, MBA, FACP, FASCO, has been a member of Texas Oncology, P.A. since 1992 and serves on the teaching faculty for the internal medicine training program at Methodist Hospitals of Dallas. He is Chair of ASCO's Cancer Education Committee, and serves on the Leadership Development Working Group and Ethics Committee. Dr. Cox is interested in new models/structures of care delivery.

Don S. Dizon, MD, FACP, is formerly an Associate Professor at The Warren Alpert Medical School of Brown University and is now affiliated with Harvard Medical School. He practices medical gynecologic oncology at the Massachusetts General Hospital (MGH) Cancer Center, where he also is Founder and Director of the Oncology Sexual Health Clinic. Dr. Dizon serves as Chair-Elect for ASCO's Cancer Communications Committee. In addition to his regular column on, which has been honored with APEX awards in 2013 and 2014, he is a blogger for MGH and Deputy Editor at UpToDate. Follow Dr. Dizon on Twitter @drdonsdizon.
Linda R. Duska, MDLinda R. Duska, MD, is an Associate Professor with tenure and the Fellowship Director for Gynecologic Oncology at the University of Virginia (UVA). She is an active member of the Gynecology Oncology Group, serving on multiple committees, as well as the author of several investigator-initiated clinical trials at UVA. Her research interests include the evaluation of novel therapeutics and targeted therapy for ovarian and endometrial cancers. She has a strong interest in health policy and is working toward a Master's degree in Public Health. Dr. Duska is active in the Foundation for Women's Cancers, where she is Chair of the Advocacy Board.
Michael Fisch, MD, MPH Michael Fisch, MD, MPH, is Chair of the Department of General Oncology at The University of Texas MD Anderson Cancer Center. His research interests include symptom management, palliative care, cardiotoxicity, patient experience, and health care disparities. He currently serves as Chair to the Palliative Care in Oncology Symposium Planning Committee, and previously served as Chair of ASCO's Integrated Media and Technology Committee. Follow Dr. Fisch on Twitter @fischmd.
Michael Fisch, MD, MPH Rob Fisher, MD, has been an ASCO member since 1991. He currently practices at the Longmont office of Rocky Mountain Cancer Centers in Colorado. Recognizing the need to provide online educational resources for breast cancer survivors and professionals, he is Co-Founder and is Organization President of the Pink Ribbon Survivors Network. This website hosts three separate online libraries: one for breast cancer survivors, one for cancer care professionals, and one for primary care providers. Dr. Fisher maintains an interest in strategies to improve the quality of survivorship care. Follow Dr. Fisher on Twitter @RobertEFisher1.
L. Michael Glodé, MD, FACP, FASCO, is a Professor in the Division of Medical Oncology at the School of Medicine at the University of Colorado Denver. He previously served as Chair of ASCO's Integrated Media and Technology and Cancer Education Committees.

David L. Graham, MD, is the Physician Administrator at Levine Cancer Center, in Charlotte, North Carolina. He is Chair of ASCO's Integrated Media and Technology Committee and an Associate Editor for the ASCO University Editorial Board. His medical interests include genitourinary and hematologic malignancies and neuroendocrine tumors. Follow Dr. Graham on Twitter @DavidGrahamMD.

Clifford A. Hudis, MD, is Chief of the Breast Cancer Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center, and a professor in the Department of Medicine at Weill Cornell Medical College. In addition to being ASCO's Immediate Past President, Dr. Hudis currently serves on the Special Awards Selection, Finance, and CancerLinQ Advisory Committees.  His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies. Follow Dr. Hudis on Twitter @CliffordHudis.
Heather M. Hylton, MS, PA-C, is the Lead Physician Assistant in the Department of Medicine at Memorial Sloan-Kettering Cancer Center. She serves on ASCO's Government Relations Committee and is an Associate Editor on the ASCO University Editorial Board. She is President of the Association of Physician Assistants in Oncology. Follow Ms. Hylton on Twitter @hmhyltonpac.
Abdul-Rahman Jazieh, MD, MPH Abdul-Rahman Jazieh, MD, MPH, is Chair of the Department of Oncology at King Abdulaziz Medical City and a Professor at King Saud bin Abdulaziz University for Health Sciences, National Guard Health Affairs, Riyadh, Saudi Arabia. Dr. Jazieh's areas of professional interest are lung cancer, professional development, and improvement of cancer care delivery. He is a member of ASCO's International Affairs Committee and International Development and Education Award (IDEA) Working Group. Follow Dr. Jazieh on Twitter @jaziehoncology.
Anne Katz, RN, PhD, certified Sexuality Counselor at CancerCare Manitoba and Clinical Nurse Specialist at the Manitoba Prostate Centre, counsels patients with a history of cancer who are experiencing sexual and relationship challenges. She is also Editor of the Oncology Nursing Forum research journal and is a faculty member of Nursing at the University of Manitoba and Athabasca University. As an author of 10 books, Dr. Katz offers insight for health care providers and consumers on the topics of illness and sexuality, as well as cancer survivorship. Follow Dr. Katz on Twitter @DrAnneKatz.
Abdul-Rahman Jazieh, MD, MPH Matthew S. Katz, MD, is the Medical Director of Radiation Oncology at Lowell General Hospital and a partner in Radiation Oncology Associates, PA. He is an Instructor at Harvard Medical School and former Chair of Communications Committee for the American Society for Radiation Oncology (ASTRO). He serves on the Communications Committee for Massachusetts Medical Society and external advisory board for Mayo Clinic's Center for Social Media. His areas of prime interest are patient education and health empowerment. Follow Dr. Katz on Twitter @subatomicdoc.
Michael P. Link, MD, FASCO, is the Lydia J. Lee Professor in Pediatric Oncology at Stanford University School of Medicine. He is an ASCO Past President and current Chair of the Special Awards Selection Committee. His research interests include the biology and management of non-Hodgkin lymphoma and Hodgkin disease in children and the treatment of bone and soft-tissue sarcomas.
Abdul-Rahman Jazieh, MD, MPH William S. Loui, MD, FACP, is a medical oncologist in private practice in Hawaii. He is on the faculty at the University of Hawaii, John A. Burns School of Medicine. He has been honored by the Susan G. Komen for the Cure in Hawaii for his innovative work with minority breast cancer patients. He is Past President of the Hawaii Society of Clinical Oncology and has served the Society as a member of ASCO's Health Disparities Advisory Group, now the Health Disparities Committee.
Merry Jennifer Markham, MD, FACP, is an Assistant Professor in the Division of Hematology and Oncology at the University of Florida. She specializes in medical gynecologic oncology and lymphoma, and she is the Program Leader for the UF Health Cancer Center’s Multidisciplinary Gynecologic Oncology Program. She serves on ASCO’s Cancer Communications Committee and the QOPI Steering Group. Follow Dr. Markham on Twitter @DrMarkham.


Frank L. Meyskens, Jr., MD, is Professor of Medicine, Biological Chemistry, Public Health, and Epidemiology and Director Emeritus at the UC Irvine Health Chao Family Comprehensive Cancer Center and Vice-Dean School of Medicine at the University of California, Irvine. He is Immediate Past Chair of ASCO's Cancer Prevention Committee and has been an ASCO member since 1978. Dr. Meyskens welcomes you to his blog—to his "White Coat Conversations." Follow Dr. Meyskens on Twitter @FrankLMeyskens.


Robert S. Miller, MD, FACP, FASCO, is a medical oncologist specializing in breast cancer and medical informatics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He currently is Editor-in-Chief of the Cancer.Net Editorial Board and serves on the Cancer Communications Committee. Previously, he served on the ASCO Board of Directors. Follow Dr. Miller on Twitter @rsm2800.



Beverly Moy, MD, MPH, is the Clinical Director of the Breast Oncology Program and a medical oncologist at Massachusetts General Hospital. Her research interests include breast cancer clinical trials and racial and ethnic disparities in cancer care. Dr. Moy is a past Chair of ASCO's Advisory Group on Health Disparities and Ethics Committee. She currently serves on ASCO's Cancer Education Committee and Breast Cancer Consensus Panel. 

Richard T. Penson, MD, MRCP, is Associate Professor of Medicine at Harvard Medical School and Clinical Director of Medical Gynecologic Oncology at Massachusetts General Hospital. His oncology practice is devoted almost exclusively to gynecologic oncology and clinical research. Dr. Penson is one of the chairs for the Institutional Review Board for Dana-Farber/Partners CancerCare and sits on the Ovarian Committee for the National Comprehensive Cancer Network, the Gynecologic Oncology Group committee for Health Outcomes Research, and the Editorial Board of The Oncologist and Medical Humanities.
George W. Sledge, Jr., MD, FASCO, is the Ballve-Lantero Professor of Oncology and Professor of Medicine and Pathology at Indiana University Simon Cancer Center. His research interests include molecular and tumor biology, growth factors, and anti-angiogenic therapy related to breast cancer.  In addition to being an ASCO Past President, he currently serves as the Immediate Past Chair of the Bylaws Committee and sits on the Leadership Development Working Group and CancerLinQ Advisory Committee.

Sandra M. Swain, MD, is the Medical Director of the Washington Cancer Institute at the MedStar Washington Hospital Center; a Professor of Medicine at Georgetown University; and an active member of the NRG. She is a Past President of ASCO and currently serves on the Conquer Cancer Foundation Board of Directors. Her research interests include evaluation of novel therapeutics and targeted therapy for locally advanced, specifically inflammatory , and metastatic breast cancer, cardiotoxicity of current therapies, adjuvant therapy of breast cancer, and health care disparities.
Michael A. Thompson, MD, PhD Michael A. Thompson, MD, PhD, is a Hematologist/Oncologist for Aurora Cancer Care and is the Medical Director of Early Cancer Research at Aurora Health Care, in Wisconsin. He participated in the ASCO Leadership Development Program and Integrated Media and Technology Committee. He currently serves on the ASCO Cancer Research and Cancer Education Committees as well as the Community Research Forum. Follow Dr. Thompson on Twitter @mtmdphd.
Peter Paul Yu, MD, FACP, FASCO, is a medical oncologist and hematologist and Director of Cancer Research at Palo Alto Medical Foundation, where he worked since 1989. In addition to his role as the 2014-2015 President of ASCO, Dr. Yu also serves on the Scientific Program, Nominating, Government Relations, and Special Awards Selection Committees. Follow Dr. Yu on Twitter @YupOnc.
S. Yousuf Zafar, MD, MHS, is an Associate Professor and gastrointestinal oncologist at the Duke Cancer Institute and Duke Clinical Research Institute. He is a health services researcher with interests in the cost of care and how costs impact cancer patients' experiences. Dr. Zafar serves on ASCO's Health Disparities, AHRQ VLC Project Advisory, Quality Symposium Planning Committee, and Supportive Care Guideline Advisory Group. Follow Dr. Zafar on Twitter @yzafar.